Preliminary Safety and Efficacy Report of a Randomized Trial of Alemtuzumab vs Chlorambucil as Front-Line Therapy in 297 Patients with Progressive B-Cell Chronic Lymphocytic Leukemia.
| Autor: | Hillmen, Peter, Skotnicki, Aleksander B., Robak, Tadeusz, Mayer, Jiri, Jaksic, Branimir, Vukovic, Vojo *, Weitman, Steven |
|---|---|
| Zdroj: | In Blood 16 November 2004 104(11):2505-2505 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|